세계의 소화제 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)
Digestive Remedies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
상품코드:1563101
리서치사:Persistence Market Research
발행일:2024년 09월
페이지 정보:영문 300 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
Persistence Market Research는 전 세계 소화제 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 통찰력을 제공합니다.
주요 인사이트
소화제 시장 규모(2024년) : 197억 3,186만 1,000달러
예측 시장 규모(2033년) : 285억 7,442만 6,000달러
세계 시장 성장률(CAGR 2024-2033년까지) : 4.2%
소화제 시장 - 조사 범위
소화제에는 소화 불량, 산성 역류, 변비, 과민성 장 증후군(IBS)과 같은 소화기계의 건강 문제를 치료하기 위한 광범위한 제품이 포함됩니다. 시장은 제산제, 완하제, 설사, 프로바이오틱스 등 제품 유형별, 소매 약국, 병원 약국, 전자상거래 플랫폼 등 최종 용도 부문별로 구분됩니다.
시장 성장 촉진요인:
세계의 소화기계 치료 시장은 소화기계 질환과 생활 습관병 증가에 의해 시판(OTC) 소화기계 제품 수요가 급증하고 있는 것으로 견인하고 있습니다. 창자 건강에 대한 소비자의 의식 증가와 자기 치료 지향 증가도 이 시장의 확대를 뒷받침하고 있습니다. 일부 지역에서는 고령화로 소화기계의 문제가 발생하기 쉬워지고 있어 소화기계 치료 수요를 더욱 밀어 올리고 있습니다. 게다가 가공식품의 소비 증가, 앉기 쉬운 라이프스타일, 스트레스가 소화기계 문제의 유병률 상승에 기여하고 있어 시장의 성장을 가속하고 있습니다. 또, 허브나 천연 소화제의 채용 등, 제품 처방의 기술적 진보도 건강 지향의 소비자에게 어필하고 있습니다.
시장 성장 억제요인:
큰 성장 가능성이 있음에도 불구하고 소화 기관용 치료 시장은 엄격한 규제 요구 사항, 특히 완하제 및 제산제와 같은 특정 소화 기관 치료의 장기 사용으로 인한 부작용에 대한 우려와 같은 문제에 직면 해 있습니다. 또 원재료 가격의 변동이나 선진적인 소화기계 치료 중에는 고가의 것도 있어 시장 성장의 억제요인이 되고 있습니다. 게다가 의약품의 소화기관용 제품의 대체품으로서 자연요법이나 영양보조식품을 선호하는 경향이 강해져 일부 지역에서는 기존의 소화기관용 치료의 성장이 제한될 수 있습니다. 이러한 과제를 해결하기 위해 신흥국 시장 진출 기업은 안전하고 자연스럽고 혁신적인 소화기 건강 보조제 개발에 주력하고 있습니다.
시장 기회:
소화기계 치료 시장은 특히 프로바이오틱스와 프리바이오틱스 부문에서 장의 건강을 유지하는 역할을 인식하고 있으며, 여러 성장 기회를 제공합니다. 예방 의학에 대한 관심 증가와 더불어 천연 재료와 식물 유래 소화기계 솔루션을 요구하는 소비자의 요구는 기술 혁신과 제품 개발의 큰 기회가 됩니다. 전자상거래 부문의 확대는 또한 시장 진출기업이 보다 폭넓은 소비자층에 도달할 수 있는 기회를 제공하고 OTC 소화제에 대한 쉬운 접근을 제공합니다. 게다가 IBS와 크론병과 같은 특정 소화기 질환에 대한 맞춤형 의료 및 표적 요법에 대한 관심 증가는 시장 성장의 새로운 길을 열고 있습니다.
이 보고서에서 다루는 주요 질문
소화제 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
소화제 부문에서 가장 수요가 높은 제품 유형은?
기술 진보와 제품 혁신은 경쟁 구도에 어떤 영향을 미치는가?
소화기관 치료 시장의 주요 진출기업은 누구이며 시장의 관련성을 유지하기 위해 어떤 전략을 사용하고 있는가?
소화제 시장의 미래를 형성하는 새로운 동향과 기회는 무엇인가?
목차
제1장 주요 요약
제2장 시장 개요
시장 범위/분류
시장의 정의/범위/제한
제3장 주요 시장 동향
시장에 영향을 미치는 주요 동향
프리바이오틱스의 이점에 관한 소비자의 의식 향상
소아용 소화 효소 수요가 증가
제품 혁신/개발 동향
제4장 중요한 성공 요인
제품의 채용/사용 상황 분석
제품 USP/특징
제5장 세계 시장 - 가격 분석
지역별 가격 분석
세계 평균 가격 분석 벤치마크
제6장 세계 시장 수요(가치 USD Mn) 분석
과거 시장 매출(100만 달러) 분석, 2019-2023년
현재와 장래 시장 매출(100만 달러) 예측, 2024-2033년
전년대비 성장 동향 분석
절대 수익 기회
제7장 시장 배경
거시경제 요인
예측요인 - 관련성과 영향
밸류체인
세계의 식음료 업계의 전망
세계의 제약 업계 개요
정책의 전개와 규제의 시나리오
시장 역학
세계 수급 분석
제8장 제품 유형별 세계 시장 분석
소개
2019-2023년의 제품 유형별 시장 규모(100만 달러)와 수량 분석
현재와 장래 시장 규모(100만 달러)와 제품 유형별 수량 분석과 예측, 2024-2033년
캡슐
액체/음료
분말
젤
기타(정제, 타블렛, 구미)
제품 유형별 시장의 매력 분석
제9장 공급원별 세계 시장 분석
소개
2019-2023년공급원별 시장 규모(100만 달러)와 수량 분석
현재와 장래 시장 규모(100만 달러)와 공급원별 수량 분석과 예측, 2024-2033년
프리바이오틱스
프로바이오틱스
식품 효소
공급원별 시장의 매력 분석
제10장 성질별 세계 시장 분석
소개
2019-2023년의 성질별 시장 규모(100만 달러)와 수량 분석
현재와 장래 시장 규모(100만 달러)와 성질별 수량 분석과 예측, 2024-2033년
유기농
기존
성질별 시장의 매력 분석
제11장 유통채널별 세계 시장 분석
소개
2019-2023년 유통채널별 시장 규모(100만 달러)와 수량 분석
현재와 장래 시장 규모(100만 달러)와 유통채널별 수량 분석과 예측, 2024-2033년
의약품 및 약국
하이퍼마켓/슈퍼마켓
편의점
직영점
온라인 소매
기타 소매업
유통 채널별 시장의 매력 분석
제12장 지역별 세계 시장 분석
소개
2019-2023년 지역별 시장 규모(100만 달러)와 수량 분석
현재 시장 규모(100만 달러)와 지역별 수량 분석과 예측, 2024-2033년
북미
라틴아메리카
유럽
동아시아
남아시아와 태평양
중동 및 아프리카
지역별 시장의 매력 분석
제13장 북미 시장 분석
제14장 라틴아메리카 시장 분석
제15장 유럽 시장 분석
제16장 남아시아와 태평양 시장 분석
제17장 동아시아 시장 분석
제18장 중동 및 아프리카 시장 분석
제19장 국가별 시장 분석, 2024년
소개
미국
캐나다
멕시코
브라질
아르헨티나
독일
이탈리아
프랑스
영국
스페인
폴란드
러시아
중국
일본
한국
인도
호주 및 뉴질랜드
터키
남아프리카
제20장 시장 구조 분석
기업 Tier별 시장 분석(소화제)
시장 집중
시장현재분석
제21장 경쟁 분석
경쟁 대시보드
경쟁의 상세
Johnson &Johnson, Inc.
Bayer AG
Sanofi
Procter &Gamble Co.
Jiangzhong Pharmaceutical Co Ltd
Abbott Laboratories Inc.
Reckitt Benckiser Group Plc(RB)
Takeda Pharmaceutical Co Ltd.
Pfizer
GlaxoSmithKline Plc
Menarini Group
Taisho Pharmaceutical Holdings Co Ltd.
Purdue Pharma LP
Others(Available on Request)
제22장 사용된 전제조건과 약어
제23장 조사 방법
JHS
영문 목차
영문목차
Persistence Market Research has recently released a comprehensive report on the worldwide market for digestive remedies. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Global Market Growth Rate (CAGR 2024 to 2033): 4.2 %
Digestive Remedies Market - Report Scope:
Digestive remedies include a broad range of products aimed at treating digestive health issues such as indigestion, acid reflux, constipation, and irritable bowel syndrome (IBS). The market is segmented by product type, including antacids, laxatives, anti-diarrheal drugs, and probiotics, and by end-use sectors such as retail pharmacies, hospital pharmacies, and e-commerce platforms.
Market Growth Drivers:
The global digestive remedies market is driven by rising incidences of digestive disorders and lifestyle diseases, which have led to a surge in demand for over-the-counter (OTC) digestive products. Increasing consumer awareness of gut health and the growing preference for self-medication have also supported the expansion of this market. Aging populations in several regions are more prone to digestive problems, further boosting the demand for digestive remedies. Additionally, the rising consumption of processed foods, sedentary lifestyles, and stress are contributing to the increasing prevalence of digestive issues, driving growth in the market. Technological advancements in product formulations, including the introduction of herbal and natural digestive remedies, are also appealing to health-conscious consumers.
Market Restraints:
Despite significant growth potential, the digestive remedies market faces challenges such as stringent regulatory requirements and concerns about the side effects of long-term use of certain digestive drugs, particularly laxatives and antacids. Fluctuations in raw material prices and the high cost of some advanced digestive treatments also pose limitations to market growth. Furthermore, the growing preference for natural remedies and dietary supplements as alternatives to pharmaceutical digestive products could limit the growth of traditional digestive remedies in some regions. To address these challenges, market players are focusing on developing safe, natural, and innovative digestive health products.
Market Opportunities:
The digestive remedies market presents several growth opportunities, particularly in the area of probiotics and prebiotics, which are increasingly recognized for their role in maintaining gut health. The growing interest in preventive healthcare, along with consumer demand for natural and plant-based digestive solutions, offers significant opportunities for innovation and product development. The expanding e-commerce sector also provides an opportunity for market players to reach a broader consumer base, offering easy access to OTC digestive remedies. Furthermore, the increasing focus on personalized medicine and targeted therapies for specific digestive issues, such as IBS and Crohn's disease, is opening up new avenues for market growth.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the digestive remedies market globally?
Which product types are witnessing the highest demand in the digestive remedies sector?
How are technological advancements and product innovations influencing the competitive landscape?
Who are the key players in the digestive remedies market, and what strategies are they using to maintain market relevance?
What emerging trends and opportunities will shape the future of the digestive remedies market?
Competitive Intelligence and Business Strategy:
Leading players in the global digestive remedies market, including Bayer AG, GlaxoSmithKline Plc, and Johnson & Johnson, are focusing on expanding their product portfolios with a range of digestive health solutions, including both traditional pharmaceuticals and natural remedies. These companies are investing in research and development to create innovative formulations with improved efficacy and fewer side effects. Collaborations with healthcare professionals, pharmacies, and e-commerce platforms are key strategies for promoting digestive remedies to a broader audience. Furthermore, sustainability initiatives, such as eco-friendly packaging and responsible sourcing of natural ingredients, are gaining importance as consumer preferences shift towards more environmentally conscious products.
Companies Covered in This Report
Johnson & Johnson, Inc
Bayer AG
Sanofi
Procter & Gamble Co.
Jiangzhong Pharmaceutical Co Ltd
Abbott Laboratories Inc.
Reckitt Benckiser Group Plc (RB)
Takeda Pharmaceutical Co Ltd.
Pfizer
GlaxoSmithKline Plc
Menarini Group
Taisho Pharmaceutical Holdings Co Ltd.
Purdue Pharma LP
Digestive Remedies Industry Research by Category
By Product Type:
Capsules
Liquid/Drinkable
Powder
Gels
Others(Pills, Tablet, Gummy)
By Nature:
Organic
Conventional
By Source:
Prebiotic
Probiotic
Food Enzymes
By Sales Channel:
Pharmaceutical & Drug Store
Hypermarket/Supermarket
Convenience Store
Direct Store
Online Retail
Other Retail Format
By Region:
North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.1.1. Increasing Consumer Awareness on Benefits of Prebiotics
3.1.2. High Demand of Pediatric Digestive Enzymes
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
5. Global Market - Pricing Analysis
5.1. Regional Pricing Analysis
5.2. Global Average Pricing Analysis Benchmark
6. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global GDP and Infrastructure Investment
7.1.3. International Trade
7.1.4. Global Industry Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Top Companies Historical Growth
7.2.2. GDP Growth forecast
7.2.3. Manufacturing Industry forecast
7.2.4. Global Urbanization Growth Outlook
7.2.5. Business Climate
7.3. Value Chain
7.3.1. Raw Material Suppliers
7.3.2. Product Manufacturers
7.3.3. Application Sectors
7.4. Global Food & Beverage Industry Outlook
7.5. Global Pharmaceutical Industry Overview
7.6. Policy Developments and Regulatory Scenario
7.7. Market Dynamics
7.7.1. Drivers
7.7.2. Restraints
7.7.3. Opportunity Analysis
7.8. Global Supply Demand Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type
8.1. Introduction
8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2033
8.3.1. Capsules
8.3.2. Liquid/Drinkable
8.3.3. Powder
8.3.4. Gels
8.3.5. Others (Pills, Tablet, Gummy)
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Source
9.1. Introduction
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Source, 2019-2023
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Source, 2024-2033
9.3.1. Prebiotic
9.3.2. Probiotic
9.3.3. Food Enzymes
9.4. Market Attractiveness Analysis By Source
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Nature
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Nature, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Nature, 2024-2033
10.3.1. Organic
10.3.2. Conventional
10.4. Market Attractiveness Analysis By Nature
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Sales Channel
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2019-2023
11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2024-2033
11.3.1. Pharmaceutical & Drug Store
11.3.2. Hypermarket/Supermarket
11.3.3. Convenience Store
11.3.4. Direct Store
11.3.5. Online Retail
11.3.6. Other Retail Format
11.4. Market Attractiveness Analysis By Sales Channel
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia and Pacific
12.3.6. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product Type
13.3.3. By Source
13.3.4. By Nature
13.3.5. By Sales Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Source
13.4.4. By Nature
13.4.5. By Sales Channel
13.5. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product Type
14.3.3. By Source
14.3.4. By Nature
14.3.5. By Sales Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Source
14.4.4. By Nature
14.4.5. By Sales Channel
14.5. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Poland
15.3.1.9. Rest of Europe
15.3.2. By Product Type
15.3.3. By Source
15.3.4. By Nature
15.3.5. By Sales Channel
15.4. Market Attractiveness Analysis
15.4.1. By Product Type
15.4.2. By Source
15.4.3. By Nature
15.4.4. By Sales Channel
15.5. Drivers and Restraints - Impact Analysis
16. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. ASEAN
16.3.1.3. Oceania
16.3.1.4. Rest of South Asia & Pacific
16.3.2. By Product Type
16.3.3. By Source
16.3.4. By Nature
16.3.5. By Sales Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Source
16.4.4. By Nature
16.4.5. By Sales Channel
16.5. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product Type
17.3.3. By Source
17.3.4. By Nature
17.3.5. By Sales Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Source
17.4.4. By Nature
17.4.5. By Sales Channel
17.5. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. GCC
18.3.1.2. Turkey
18.3.1.3. Nigeria
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East & Africa
18.3.2. By Product Type
18.3.3. By Source
18.3.4. By Nature
18.3.5. By Sales Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Source
18.4.4. By Nature
18.4.5. By Sales Channel
18.5. Drivers and Restraints - Impact Analysis
19. Country Wise Market Analysis, 2024
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Market Analysis
19.2.1. By Product Type
19.2.2. By Source
19.2.3. By Nature
19.2.4. By Sales Channel
19.3. Canada Market Analysis
19.3.1. By Product Type
19.3.2. By Source
19.3.3. By Nature
19.3.4. By Sales Channel
19.4. Mexico Market Analysis
19.4.1. By Product Type
19.4.2. By Source
19.4.3. By Nature
19.4.4. By Sales Channel
19.5. Brazil Market Analysis
19.5.1. By Product Type
19.5.2. By Source
19.5.3. By Nature
19.5.4. By Sales Channel
19.6. Argentina Market Analysis
19.6.1. By Product Type
19.6.2. By Source
19.6.3. By Nature
19.6.4. By Sales Channel
19.7. Germany Market Analysis
19.7.1. By Product Type
19.7.2. By Source
19.7.3. By Nature
19.7.4. By Sales Channel
19.8. Italy Market Analysis
19.8.1. By Product Type
19.8.2. By Source
19.8.3. By Nature
19.8.4. By Sales Channel
19.9. France Market Analysis
19.9.1. By Product Type
19.9.2. By Source
19.9.3. By Nature
19.9.4. By Sales Channel
19.10. U.K. Market Analysis
19.10.1. By Product Type
19.10.2. By Source
19.10.3. By Nature
19.10.4. By Sales Channel
19.11. Spain Market Analysis
19.11.1. By Product Type
19.11.2. By Source
19.11.3. By Nature
19.11.4. By Sales Channel
19.12. Poland Market Analysis
19.12.1. By Product Type
19.12.2. By Source
19.12.3. By Nature
19.12.4. By Sales Channel
19.13. Russia Market Analysis
19.13.1. By Product Type
19.13.2. By Source
19.13.3. By Nature
19.13.4. By Sales Channel
19.14. China Market Analysis
19.14.1. By Product Type
19.14.2. By Source
19.14.3. By Nature
19.14.4. By Sales Channel
19.15. Japan Market Analysis
19.15.1. By Product Type
19.15.2. By Source
19.15.3. By Nature
19.15.4. By Sales Channel
19.16. S. Korea Market Analysis
19.16.1. By Product Type
19.16.2. By Source
19.16.3. By Nature
19.16.4. By Sales Channel
19.17. India Market Analysis
19.17.1. By Product Type
19.17.2. By Source
19.17.3. By Nature
19.17.4. By Sales Channel
19.18. Australia and New Zealand Market Analysis
19.18.1. By Product Type
19.18.2. By Source
19.18.3. By Nature
19.18.4. By Sales Channel
19.19. Turkey Market Analysis
19.19.1. By Product Type
19.19.2. By Source
19.19.3. By Nature
19.19.4. By Sales Channel
19.20. South Africa Market Analysis
19.20.1. By Product Type
19.20.2. By Source
19.20.3. By Nature
19.20.4. By Sales Channel
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies (Digestive Remedies)
20.2. Market Concentration
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Johnson & Johnson, Inc.
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.2. Bayer AG
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.3. Sanofi
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.4. Procter & Gamble Co.
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.5. Jiangzhong Pharmaceutical Co Ltd
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.6. Abbott Laboratories Inc.
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.7. Reckitt Benckiser Group Plc (RB)
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.8. Takeda Pharmaceutical Co Ltd.
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
21.2.8.4. Sales Footprint
21.2.8.5. Strategy Overview
21.2.9. Pfizer
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
21.2.9.4. Sales Footprint
21.2.9.5. Strategy Overview
21.2.10. GlaxoSmithKline Plc
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
21.2.10.4. Sales Footprint
21.2.10.5. Strategy Overview
21.2.11. Menarini Group
21.2.11.1. Overview
21.2.11.2. Product Portfolio
21.2.11.3. Profitability by Market Segments (Product/Channel/Region)
21.2.11.4. Sales Footprint
21.2.11.5. Strategy Overview
21.2.12. Taisho Pharmaceutical Holdings Co Ltd.
21.2.12.1. Overview
21.2.12.2. Product Portfolio
21.2.12.3. Profitability by Market Segments (Product/Channel/Region)
21.2.12.4. Sales Footprint
21.2.12.5. Strategy Overview
21.2.13. Purdue Pharma LP
21.2.13.1. Overview
21.2.13.2. Product Portfolio
21.2.13.3. Profitability by Market Segments (Product/Channel/Region)
21.2.13.4. Sales Footprint
21.2.13.5. Strategy Overview
21.2.14. Others (Available on Request)
21.2.14.1. Overview
21.2.14.2. Product Portfolio
21.2.14.3. Profitability by Market Segments (Product/Channel/Region)
